Stock HSCS HEART TEST LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
5.5 USD -19.24% Intraday chart for Heart Test Laboratories, Inc. -11.29% -67.84%
24/04 HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG CI
26/03 HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
CI
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
CI
Heart Test Laboratories, Inc. Enters into Multiple Definitive License Agreements with Icahn School of Medicine At Mount Sinai
CI
HeartSciences Completes License Agreements on AI Cardiovascular Algorithms With Icahn School of Medicine at Mount Sinai
MT
Heart Test Laboratories, Inc. Announces That Its Myovista® Wavecgtm Has Been Selected by Cardiact Ltd (?Cardiact?) to Be Used in Its Heart Screening Program of Members of the Association of Garda Sergeants and Inspectors
CI
Heart Test Laboratories, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
CI
Heart Test Laboratories Has Distribution Accord With Denmark's FJ Medical
MT
Heart Test's MyoVista wavECG Selected by PanaceaFlo for Heart Screening Evaluation Study in Dublin
MT
Heart Test Laboratories, Inc. Announces It?s MyoVista wavECGTM Selection to Be Used in Irish Heart Screening Evaluation
CI
Heart Test Laboratories Gets Patent Allowance Notice From European Patent Office
MT
Heart Test Laboratories, Inc.  Announces Further Expansion of Artificial Intelligence Patent Portfolio
CI
Heart Test Laboratories, Inc Announces MyoVista® wavECGTM Selects for Commercial Use in Clinical Practice by the Naya Imaging Center in Hvidore, Denmark
CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023
CI
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results
GL
HEART TEST LABORATORIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Heart Test Laboratories Receives Israeli Patent for MyoVista Wavelet
MT
Heart Test Laboratories Receives South Korean Patent for MyoVista
MT
HEART TEST LABORATORIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HSCS Stock
  4. News Heart Test Laboratories, Inc.
  5. Highlights